Organogenesis Holdings Inc - Class A — Quarterly Financial Statistics (NASDAQ:ORGO) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -2.15 M10.94 M19.93 M32.87 M-3.08 M-39.42 M 10.31 M Cash from investing activities 2.57 M3.36 M3.63 M3.64 M2.23 M4.65 M 14.15 M Cash from financing activities 1.68 M21.63 M2.06 M288 K10.21 M4.81 M 17.36 M Free cash flow -4.72 M7.58 M16.31 M29.23 M-5.31 M-44.07 M -3.84 M

Notizie

Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript

Avista Healthcare Partners annuncia tre promozioni chiave nel team d’investimento

Organogenesis Holdings estende i contratti di locazione per le strutture di Canton fino al 2032

Organogenesis Holdings extends leases for Canton facilities through 2032

Coupang and Regencell among market cap stock movers on Friday

Organogenesis mantiene rating Buy di BTIG dopo decisione CMS LCD

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision

Il titolo Organogenesis sale dopo l’avvio della domanda FDA per trattamento dell’artrite al ginocchio

Organogenesis stock rises after initiating FDA application for knee arthritis treatment

Organogenesis avvia la revisione progressiva della FDA per il trattamento dell’artrite al ginocchio

Organogenesis begins FDA rolling review for knee arthritis treatment

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)